A Phase 1, Open Label Two Period Crossover Study To Investigate The Effects Of Multiple Oral Doses Of Filibuvir On The Steady State Pharmacokinetics Of Oral Contraceptive Steroids In Healthy Female Subjects.

Trial Profile

A Phase 1, Open Label Two Period Crossover Study To Investigate The Effects Of Multiple Oral Doses Of Filibuvir On The Steady State Pharmacokinetics Of Oral Contraceptive Steroids In Healthy Female Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Apr 2011

At a glance

  • Drugs Ethinylestradiol/levonorgestrel; Filibuvir
  • Indications Pregnancy; Viral infections
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 28 Apr 2011 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
    • 01 Feb 2011 Planned end date changed from Jan 2011 to Feb 2011 as reported by ClinicalTrials.gov.
    • 03 Jan 2011 Planned End Date changed from 1 Dec 2010 to 1 Jan 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top